Literature DB >> 3105680

Systolic and diastolic blood pressures as predictors of coronary heart disease in middle aged Norwegian men.

A Tverdal.   

Abstract

Systolic and diastolic blood pressures were compared as predictors of mortality from coronary heart disease in Norwegian men aged 35-49. A total of 39,207 men were followed up for an average of 8.9 years; 385 died of coronary heart disease. Diastolic blood pressure seemed to be the better predictor, the difference being most pronounced in the age group 35-39. At this age 26% more deaths from coronary heart disease were found in the upper quintile of diastolic blood pressure compared with the upper quintile of systolic blood pressure. At ages 45-49 there were almost the same numbers of deaths from coronary heart disease in the upper quintiles of systolic and diastolic pressures. These findings suggest that the relative predictive strength of systolic and diastolic blood pressure may be dependent on age. Furthermore, for very obese men the association between blood pressure and death from coronary heart disease is much weaker.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3105680      PMCID: PMC1245731          DOI: 10.1136/bmj.294.6573.671

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  9 in total

1.  The Oslo study. Cardiovascular disease in middle-aged and young Oslo men.

Authors:  P Leren; E M Askevold; O P Foss; A Froili; D Grymyr; A Helgeland; I Hjermann; I Holme; P G Lund-Larsen; K R Norum
Journal:  Acta Med Scand Suppl       Date:  1975

2.  The cardiovascular disease study in Norwegian counties. Background and organization.

Authors:  K Bjartveit; O P Foss; T Gjervig; P G Lund-Larsen
Journal:  Acta Med Scand Suppl       Date:  1979

3.  Estimation of the multivariate logistic risk function: a comparison of the discriminant function and maximum likelihood approaches.

Authors:  M Halperin; W C Blackwelder; J I Verter
Journal:  J Chronic Dis       Date:  1971-07

4.  Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham study.

Authors:  W B Kannel; T Gordon; M J Schwartz
Journal:  Am J Cardiol       Date:  1971-04       Impact factor: 2.778

5.  A multivariate analysis of the risk of coronary heart disease in Framingham.

Authors:  J Truett; J Cornfield; W Kannel
Journal:  J Chronic Dis       Date:  1967-07

6.  Five-year mortality in the city of Bergen, Norway, according to age, sex and blood pressure.

Authors:  I Holme; H T Waaler
Journal:  Acta Med Scand       Date:  1976

7.  The Tromsøo heart study. Methods and main results of the cross-sectional study.

Authors:  D S Thelle; O H Føorde; K Try; E H Lehmann
Journal:  Acta Med Scand       Date:  1976

8.  Systolic and diastolic blood pressures as predictors of coronary heart disease mortality in the Whitehall study.

Authors:  M J Lichtenstein; M J Shipley; G Rose
Journal:  Br Med J (Clin Res Ed)       Date:  1985-07-27

9.  Is the relationship between blood pressure and cardiovascular risk dependent on body mass index?

Authors:  F Cambien; J M Chretien; P Ducimetiere; L Guize; J L Richard
Journal:  Am J Epidemiol       Date:  1985-09       Impact factor: 4.897

  9 in total
  12 in total

Review 1.  Arterial compliance and blood pressure.

Authors:  S J Marchais; A P Guerin; B Pannier; G Delavaud; G M London
Journal:  Drugs       Date:  1993       Impact factor: 9.546

2.  Coffee consumption and death from coronary heart disease in middle aged Norwegian men and women.

Authors:  A Tverdal; I Stensvold; K Solvoll; O P Foss; P Lund-Larsen; K Bjartveit
Journal:  BMJ       Date:  1990-03-03

3.  The influence of circadian blood pressure changes on aortic distensibility and left ventricular diastolic function in hypertensive individuals.

Authors:  Dogan Erdogan; Hakan Gullu; Mustafa Caliskan; Ibrahim Yildirim; Semra Baycan; Ozgur Ciftci; Haldun Muderrisoglu
Journal:  Int J Cardiovasc Imaging       Date:  2005-07-20       Impact factor: 2.357

4.  Birth weight and body mass index in childhood, adolescence, and adulthood as predictors of blood pressure at age 36.

Authors:  F J Holland; O Stark; A E Ades; C S Peckham
Journal:  J Epidemiol Community Health       Date:  1993-12       Impact factor: 3.710

5.  Use of anthropometric measurements in assessing risk for coronary heart disease: a useful tool in worksite health screening?

Authors:  A Oshaug; K H Bugge; C H Bjønnes; M Ryg
Journal:  Int Arch Occup Environ Health       Date:  1995       Impact factor: 3.015

6.  Body mass index and cardiovascular mortality at different levels of blood pressure: a prospective study of Norwegian men and women.

Authors:  R Selmer; A Tverdal
Journal:  J Epidemiol Community Health       Date:  1995-06       Impact factor: 3.710

7.  APOL1 genetic variants are not associated with longitudinal blood pressure in young black adults.

Authors:  Teresa K Chen; Michelle M Estrella; Eric Vittinghoff; Feng Lin; Orlando M Gutierrez; Holly Kramer; Cora E Lewis; Jeffrey B Kopp; Norrina B Allen; Cheryl A Winkler; Kirsten B Bibbins-Domingo; Carmen A Peralta
Journal:  Kidney Int       Date:  2017-05-23       Impact factor: 18.998

8.  Coronary risk factor prevalence in a high incidence area: results from the Belfast MONICA Project.

Authors:  A E Evans; M M Kerr; E E McCrum; D McMaster; L K McCartney; M Mallaghan; C C Patterson
Journal:  Ulster Med J       Date:  1989-04

9.  Cohort Profile: The Metabolic syndrome and Cancer project (Me-Can).

Authors:  Tanja Stocks; Wegene Borena; Susanne Strohmaier; Tone Bjørge; Jonas Manjer; Anders Engeland; Dorthe Johansen; Randi Selmer; Göran Hallmans; Kilian Rapp; Hans Concin; Håkan Jonsson; Hanno Ulmer; Pär Stattin
Journal:  Int J Epidemiol       Date:  2009-04-20       Impact factor: 7.196

10.  Blood pressure trajectories in early adulthood and subclinical atherosclerosis in middle age.

Authors:  Norrina B Allen; Juned Siddique; John T Wilkins; Christina Shay; Cora E Lewis; David C Goff; David R Jacobs; Kiang Liu; Donald Lloyd-Jones
Journal:  JAMA       Date:  2014-02-05       Impact factor: 157.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.